Insulin resistance limits corneal nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control
ConclusionsNerve regeneration might be limited in individuals with type 2 diabetes and IR undergoing treatment with pioglitazone plus exenatide or insulin to improve glycemic control.
Source: Journal of Diabetes Investigation - Category: Endocrinology Authors: Georgios Ponirakis,
Muhammad A Abdul ‐Ghani,
Amin Jayyousi,
Mahmoud A Zirie,
Salma Al‐Mohannadi,
Hamad Almuhannadi,
Ioannis N Petropoulos,
Adnan Khan,
Hoda Gad,
Osama Migahid,
Ayman Megahed,
Murtaza Qazi,
Fatema AlMarri,
Fatima Al‐Khaya Tags: Clinical Trial Source Type: research
More News: Actos | Brain | Byetta | Cholesterol | Clinical Trials | Diabetes | Endocrinology | Insulin | Neurology | Study